MedTrace Logo

Clinical Trial With Artiflex Presbyopic (Artiplus)

NCT04632784 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2025-02-20

No results posted yet for this study

Summary

The purpose of this clinical trial is to evaluate the effectiveness and safety of the multifocal Artiflex Presbyopic (Artiplus) intraocular lens.

Conditions

  • Presbyopia
  • Ametropia
  • Refractive Errors
  • Myopia
  • Hyperopia

Interventions

DEVICE

Artiflex Presbyopic (Artiplus) implantation

Implantation of iris-fixated multifocal Artiflex Presbyopic IOL (Artiplus)

Sponsors & Collaborators

  • Ophtec BV

    lead INDUSTRY

Principal Investigators

  • J. Guell, MD · Instituto de Microcirugía Ocular, Barcelona, Spain

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-12
Primary Completion
2023-11-26
Completion
2026-11-26

Countries

  • South Korea
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04632784 on ClinicalTrials.gov